A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous analysis, the study, found that using the PCT biomarker to guide treatment decisions did not reduce antibiotic duration when compared to usual care.
http://dlvr.it/THXRST